These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1528 related items for PubMed ID: 16230475

  • 1. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
    Ghiringhelli F, Ménard C, Terme M, Flament C, Taieb J, Chaput N, Puig PE, Novault S, Escudier B, Vivier E, Lecesne A, Robert C, Blay JY, Bernard J, Caillat-Zucman S, Freitas A, Tursz T, Wagner-Ballon O, Capron C, Vainchencker W, Martin F, Zitvogel L.
    J Exp Med; 2005 Oct 17; 202(8):1075-85. PubMed ID: 16230475
    [Abstract] [Full Text] [Related]

  • 2. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M, Piccirillo CA.
    J Leukoc Biol; 2007 Aug 17; 82(2):335-46. PubMed ID: 17475784
    [Abstract] [Full Text] [Related]

  • 3. Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity.
    Kopp HG, Placke T, Salih HR.
    Cancer Res; 2009 Oct 01; 69(19):7775-83. PubMed ID: 19738039
    [Abstract] [Full Text] [Related]

  • 4. The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression.
    Ghiringhelli F, Ménard C, Martin F, Zitvogel L.
    Immunol Rev; 2006 Dec 01; 214():229-38. PubMed ID: 17100888
    [Abstract] [Full Text] [Related]

  • 5. RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo.
    Friese MA, Wischhusen J, Wick W, Weiler M, Eisele G, Steinle A, Weller M.
    Cancer Res; 2004 Oct 15; 64(20):7596-603. PubMed ID: 15492287
    [Abstract] [Full Text] [Related]

  • 6. Control of NK cell functions by CD4+CD25+ regulatory T cells.
    Ralainirina N, Poli A, Michel T, Poos L, Andrès E, Hentges F, Zimmer J.
    J Leukoc Biol; 2007 Jan 15; 81(1):144-53. PubMed ID: 16959895
    [Abstract] [Full Text] [Related]

  • 7. Foxp3-transduced polyclonal regulatory T cells suppress NK cell functions in a TGF-beta dependent manner.
    Zhou H, Chen L, You Y, Zou L, Zou P.
    Autoimmunity; 2010 Jun 15; 43(4):299-307. PubMed ID: 20166879
    [Abstract] [Full Text] [Related]

  • 8. IL-2/IL-18 prevent the down-modulation of NKG2D by TGF-beta in NK cells via the c-Jun N-terminal kinase (JNK) pathway.
    Song H, Hur DY, Kim KE, Park H, Kim T, Kim CW, Bang S, Cho DH.
    Cell Immunol; 2006 Jul 15; 242(1):39-45. PubMed ID: 17070508
    [Abstract] [Full Text] [Related]

  • 9. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
    Kang N, Tang L, Li X, Wu D, Li W, Chen X, Cui L, Ba D, He W.
    Immunol Lett; 2009 Aug 15; 125(2):105-13. PubMed ID: 19539651
    [Abstract] [Full Text] [Related]

  • 10. Depletion of IL-10- and TGF-beta-producing regulatory gamma delta T cells by administering a daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells.
    Seo N, Tokura Y, Takigawa M, Egawa K.
    J Immunol; 1999 Jul 01; 163(1):242-9. PubMed ID: 10384122
    [Abstract] [Full Text] [Related]

  • 11. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].
    Guo KY, Mei JZ, Yao KT.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar 01; 27(3):247-9. PubMed ID: 17425963
    [Abstract] [Full Text] [Related]

  • 12. Activation of human NK cells by plasmacytoid dendritic cells and its modulation by CD4+ T helper cells and CD4+ CD25hi T regulatory cells.
    Romagnani C, Della Chiesa M, Kohler S, Moewes B, Radbruch A, Moretta L, Moretta A, Thiel A.
    Eur J Immunol; 2005 Aug 01; 35(8):2452-8. PubMed ID: 15997468
    [Abstract] [Full Text] [Related]

  • 13. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E, Pallandre JR, Chalmers D, Ryffel B, Radlovic A, Seilles E, Rohrlich PS, Pivot X, Tiberghien P, Saas P, Borg C.
    Exp Hematol; 2007 Mar 01; 35(3):416-25. PubMed ID: 17309822
    [Abstract] [Full Text] [Related]

  • 14. Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation.
    Ghiringhelli F, Puig PE, Roux S, Parcellier A, Schmitt E, Solary E, Kroemer G, Martin F, Chauffert B, Zitvogel L.
    J Exp Med; 2005 Oct 03; 202(7):919-29. PubMed ID: 16186184
    [Abstract] [Full Text] [Related]

  • 15. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.
    Gumá M, Busch LK, Salazar-Fontana LI, Bellosillo B, Morte C, García P, López-Botet M.
    Eur J Immunol; 2005 Jul 03; 35(7):2071-80. PubMed ID: 15940674
    [Abstract] [Full Text] [Related]

  • 16. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
    Sheu BC, Chiou SH, Lin HH, Chow SN, Huang SC, Ho HN, Hsu SM.
    Cancer Res; 2005 Apr 01; 65(7):2921-9. PubMed ID: 15805295
    [Abstract] [Full Text] [Related]

  • 17. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW, Liao CH, Ying C, Chang CJ, Lin CM.
    Clin Immunol; 2006 Apr 01; 119(1):21-31. PubMed ID: 16406844
    [Abstract] [Full Text] [Related]

  • 18. Soluble HLA-I-mediated secretion of TGF-beta1 by human NK cells and consequent down-regulation of anti-tumor cytolytic activity.
    Ghio M, Contini P, Negrini S, Boero S, Musso A, Poggi A.
    Eur J Immunol; 2009 Dec 01; 39(12):3459-68. PubMed ID: 19830740
    [Abstract] [Full Text] [Related]

  • 19. Chimeric NKG2D modified T cells inhibit systemic T-cell lymphoma growth in a manner involving multiple cytokines and cytotoxic pathways.
    Zhang T, Barber A, Sentman CL.
    Cancer Res; 2007 Nov 15; 67(22):11029-36. PubMed ID: 18006849
    [Abstract] [Full Text] [Related]

  • 20. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
    Ito A, Shimura H, Nitahara A, Tomiyama K, Ito M, Kanekura T, Okumura K, Yagita H, Kawai K.
    Int Immunol; 2008 Oct 15; 20(10):1343-9. PubMed ID: 18697765
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 77.